3Tamura M, Gu JG, Matsumoto K, et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN[J]. Science, 1998, 280(5369): 1614-1619.
4Nenry TL, Patrice W, Susan T, et al. An update on DNA based BRCA1/BRCA2 genetic counseling in hereditary breast cancer[J]. Cancer Geneti a Cytogeneti, 1999, 109(2): 91-98.
6King MC, Marks JH, Mandell JB, et al. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2[J]. Science, 2003, 302(5645): 643-646.
7Huang H. Bcl-2 and breast cancer[J]. Foreign Med Sci: Cancer Section, 1999, 26: 168-169.
8Sierra A, Castellsague X, Escobedo A, et al. Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: a pathway to metastatic progression in human breast cancer[J]. Int J Cancer, 2000, 89: 142-147.
9Mu D, Chen L, Zhang X, et al. Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene[J]. Cancer Cell, 2003, 3(3): 297-302.
10Leek RD. Bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer[J]. Br J Cancer, 1994, 69: 135.
